Total submissions: 16
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Prevention |
RCV000144996 | SCV000303808 | benign | not specified | criteria provided, single submitter | clinical testing | ||
Illumina Laboratory Services, |
RCV000269263 | SCV000369248 | benign | Hyperinsulinism, Dominant/Recessive | 2016-06-14 | criteria provided, single submitter | clinical testing | |
Illumina Laboratory Services, |
RCV000326750 | SCV000369249 | benign | Transient Neonatal Diabetes, Dominant | 2016-06-14 | criteria provided, single submitter | clinical testing | |
Illumina Laboratory Services, |
RCV000388290 | SCV000369250 | benign | Permanent neonatal diabetes mellitus | 2016-06-14 | criteria provided, single submitter | clinical testing | |
Athena Diagnostics | RCV000576686 | SCV000677122 | benign | not provided | 2017-04-12 | criteria provided, single submitter | clinical testing | |
Eurofins Ntd Llc |
RCV000144996 | SCV000703631 | benign | not specified | 2017-02-12 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV000576686 | SCV001720263 | benign | not provided | 2025-02-04 | criteria provided, single submitter | clinical testing | |
Pars Genome Lab | RCV001533268 | SCV001749079 | benign | Leucine-induced hypoglycemia | 2021-07-01 | criteria provided, single submitter | clinical testing | |
Pars Genome Lab | RCV001533270 | SCV001749083 | benign | Hyperinsulinemic hypoglycemia, familial, 1 | 2021-07-01 | criteria provided, single submitter | clinical testing | |
Pars Genome Lab | RCV001533271 | SCV001749084 | benign | Diabetes mellitus, transient neonatal, 2 | 2021-07-01 | criteria provided, single submitter | clinical testing | |
Pars Genome Lab | RCV001533272 | SCV001749085 | benign | Diabetes mellitus, permanent neonatal 3 | 2021-07-01 | criteria provided, single submitter | clinical testing | |
Gene |
RCV000576686 | SCV001850606 | benign | not provided | 2018-08-09 | criteria provided, single submitter | clinical testing | This variant is associated with the following publications: (PMID: 28411266, 25955821, 26551672, 27398621, 11117432, 22209866, 17823772, 25143473, 22187380, 19587354) |
Clinical Genomics, |
RCV002226425 | SCV002505384 | benign | Type 2 diabetes mellitus | criteria provided, single submitter | research | Mutations in this gene are associated with both neonatal diabetes mellitus as well as MODY. Patients with this mutation have a better response to sulfonylureas. It doesn't cause any sensitivity toward mild hypoglycemia, an adverse effect of Sulfonylurea treatment. | |
Breakthrough Genomics, |
RCV000576686 | SCV005323553 | benign | not provided | criteria provided, single submitter | not provided | ||
Genetic Services Laboratory, |
RCV000144996 | SCV000192032 | likely benign | not specified | no assertion criteria provided | clinical testing | ||
Natera, |
RCV001277184 | SCV001464082 | benign | Hereditary hyperinsulinism | 2020-09-16 | no assertion criteria provided | clinical testing |